Editorial
doi: 10.1001/jama.2021.1395.
Blinatumomab for Treatment of Children With High-risk Relapsed B-Cell Acute Lymphoblastic Leukemia
Affiliations
- PMID: 33651075
- DOI: 10.1001/jama.2021.1395
Item in Clipboard
Editorial
Blinatumomab for Treatment of Children With High-risk Relapsed B-Cell Acute Lymphoblastic Leukemia
JAMA.
.
No abstract available
Comment on
-
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.JAMA. 2021 Mar 2;325(9):833-842. doi: 10.1001/jama.2021.0669. JAMA. 2021. PMID: 33651090 Free PMC article. Clinical Trial.
-
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.JAMA. 2021 Mar 2;325(9):843-854. doi: 10.1001/jama.2021.0987. JAMA. 2021. PMID: 33651091 Free PMC article. Clinical Trial.
Similar articles
-
Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia, who have been treated with Blinatumomab.Haematologica. 2021 Jul 1;106(7):2009-2012. doi: 10.3324/haematol.2019.241596. Haematologica. 2021. PMID: 33375769 Free PMC article.
-
Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia.Cancer Sci. 2020 Apr;111(4):1314-1323. doi: 10.1111/cas.14322. Epub 2020 Feb 11. Cancer Sci. 2020. PMID: 31971321 Free PMC article. Clinical Trial.
-
[Use of blinatumomab in children acute lymphoblastic leukemia in the Grand Ouest interregion: A chance for all].Bull Cancer. 2019 Mar;106(3):206-215. doi: 10.1016/j.bulcan.2018.11.012. Epub 2019 Jan 11. Bull Cancer. 2019. PMID: 30638898 French.
-
A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia.J Oncol Pharm Pract. 2018 Sep;24(6):453-467. doi: 10.1177/1078155217713363. Epub 2017 Jun 5. J Oncol Pharm Pract. 2018. PMID: 28583018 Review.
-
Blinatumomab for the treatment of adult acute lymphoblastic leukemia.Drugs Today (Barc). 2015 Apr;51(4):231-41. doi: 10.1358/dot.2015.51.4.2291051. Drugs Today (Barc). 2015. PMID: 26020065 Review.
Cited by
-
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia.BMC Pediatr. 2024 Sep 10;24(1):574. doi: 10.1186/s12887-024-05053-x. BMC Pediatr. 2024. PMID: 39251964 Free PMC article.
-
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission.Blood Adv. 2024 May 28;8(10):2405-2409. doi: 10.1182/bloodadvances.2023012139. Blood Adv. 2024. PMID: 38507689 Free PMC article. No abstract available.
-
Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond.Cancers (Basel). 2023 Jun 26;15(13):3346. doi: 10.3390/cancers15133346. Cancers (Basel). 2023. PMID: 37444456 Free PMC article. Review.
-
Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare TP53 c.C275T mutation: A case report.Front Oncol. 2023 Jan 31;12:1018250. doi: 10.3389/fonc.2022.1018250. eCollection 2022. Front Oncol. 2023. PMID: 36798689 Free PMC article.
-
[Chinese consensus for the bispeific T cell engager in the treatment of B-cell acute lymphoblastic leukemia (2022)].Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):448-455. doi: 10.3760/cma.j.issn.0253-2727.2022.06.002. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35968586 Free PMC article. Chinese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
